Figure 1From: Inhibition of the AKT pathway in cholangiocarcinoma by MK2206 reduces cellular viability via induction of apoptosis Dose-dependent growth reduction upon MK2206 treatment. MTT assay was used to determine cellular viability after 96 hours of treatment with MK2206 at the indicated doses. Growth reduction was significant in both cell lines at 0.5, 1, and 2 μM (p < 0.05).Back to article page